Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy

For clinical application by dendritic cell (DC)-based cancer immunotherapy, a proper adjuvant system to elicit a strong anticancer immune response is needed. Here, we investigated the potential of chorismate mutase (TBCM, Rv1885c), a putative Mycobacterium tuberculosis (TB) virulence factor, as an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hyein, Lee, So-Young, Seo, Hyejun, Kim, Dong Hyun, Lee, Duhyung, Kim, Bum-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786331/
https://www.ncbi.nlm.nih.gov/pubmed/35083095
http://dx.doi.org/10.1080/2162402X.2021.2023340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786331/
https://www.ncbi.nlm.nih.gov/pubmed/35083095
http://dx.doi.org/10.1080/2162402X.2021.2023340

Ejemplares similares